1284 results about "Risk factor" patented technology

A method for information technology (IT) and information asset risk assessment of a business relationship between a client and a third party. The method includes establishing a database. The database includes a plurality of IT information risk factors. The database is configured to receive IT risk information. The IT risk information is associated with the plurality of IT information risk factors. The plurality of IT information risk factors includes a subset of relationship risk factors. The subset of relationship risk factors are utilized for evaluating the business relationship risk between the client and the third party. The method also includes receiving IT risk information corresponding to the subset of relationship risk factors. The method continues with generating a relationship risk score. The relationship risk score is determined in response to evaluating the subset of relationship risk factors using the IT risk information corresponding to the subset of relationship risk factors.

Methods and apparatus for a smartcard system are provided which securely and conveniently provides for secure transaction completion in a contact or contactless environment. The invention utilizes selection of processing applications based on the account issuer parameters and risk factors (stored on a smartcard) and merchant system parameters and risk factors (stored on a merchant system database). The invention permits a merchant system and smartcard to exchange information useful for determining if particular transactions should be completed online or offline.

A computer system conducts transactional monitoring to detect different types of possible cases in order to prevent financial crimes and assist businesses to comply with different types of laws and regulations. The computer system derives a total risk score for each of a group of entities based on risk factors. Each of the risk factors is assigned a risk score. The computer system also detects an entity when the total risk score of the detected entity differs from a reference derived from total risk scores of the group of entities by a pre-determined margin. The computer system also assists a user to identify at least one transaction that has caused the detected entity to have a total risk score that differs from the reference derived from the total risk scores of the group of entities.

The invention relates to planning orthodontic treatment for a patient, including surgery, using biological constrains such as those arising from bone, soft tissue, and roots of patient's teeth. The invention disclosed herein provides capability to vary the movement ratio between the teeth and bone and soft tissue through treatment simulation to assess the risk factor associated with a particular treatment plan. The invention further provides capability to monitor results of the treatment to determine the actual movement ratio between the teeth and bone and soft tissue and update the database. Additionally, a method and apparatus are disclosed enabling an orthodontist or a user to create an unified three dimensional virtual craniofacial and dentition model of actual, as-is static and functional anatomy of a patient, from data representing facial bone structure; upper jaw and lower jaw; facial soft tissue; teeth including crowns and roots; information of the position of the roots relative to each other; and relative to the facial bone structure of the patient; obtained by scanning as-is anatomy of craniofacial and dentition structures of the patient with a volume scanning device; and data representing three dimensional virtual models of the patient's upper and lower gingiva, obtained from scanning the patient's upper and lower gingiva either (a) with a volume scanning device, or (a) with a surface scanning device. Such craniofacial and dentition models of the patient can be used in optimally planning treatment of a patient.

Compositions comprising omega-3 fatty acids are provided, where the compositions are useful for treating cardiovascular disease in patients suffering from chronic kidney disease (CKD), preventing its further progression, and treating underlying risk factors such as hypertension, dyslipidemia, obesity and / or diabetes. Also provided are methods of using the compositions to reduce the occurrence of or prevent major coronary events, including myocardial infarctions, in patients with CKD.

A driver advisory system is provided for use in a host vehicle and for transmitting to drivers of other vehicles information regarding the status of a driver of the host vehicle. The driver advisory system includes a sensor, a first processor and a communication unit. The sensor monitors a physical condition of the driver of the host vehicle. The sensor provides an output quantifying the physical condition of the driver of the host vehicle. The first processor receives the output provided by the sensor. The first processor calculates a risk factor as a function of the output provided by the sensor. The first processor provides an output signal having information concerning the condition of the driver of the host vehicle in response to the risk factor exceeding a predetermined threshold value. The communication unit receives the output signal from the first processor and transmitting the information for retrieval by the other vehicles in the vicinity of the host vehicle.

A computer-implemented process of developing a person-level cost model for forecasting future costs attributable to claims from members of a book of business, where person-level data are available for a substantial portion of the members of the book of business for an actual underwriting period, and the forecast of interest is for a policy period is disclosed. The process uses development universe data comprising person-level enrollment data, historical base period health care claims data and historical next period claim amount data for a statistically meaningful number of individuals. The process also provides at least one claim-based risk factor for each historical base period claim based on the claim code associated with the health care claim and provides at least one enrollment-based risk factor based on the enrollment data. The process also develops a cost forecasting model by capturing the predictive ability of the main effects and interactions of claim based risk factors and enrollment-based risk factors, with the development universe data through the application of an interaction capturing technique to the development universe data.

Methods and apparatus for a smartcard system are provided which securely and conveniently provides for secure transaction completion in a contact or contactless environment. The invention utilizes selection of processing applications based on the account issuer parameters and risk factors (stored on a smartcard) and merchant system parameters and risk factors (stored on a merchant system database). The invention permits a merchant system and smartcard to exchange information useful for determining if particular transactions should be completed online or offline.

Omega-3 fatty acid compositions comprising eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are provided, where the compositions are useful for treating, reducing the occurrence of, or preventing major adverse cardiovascular events or major coronary events in patients who have established cardiovascular disease without prior myocardial infarction, preventing their further progression, and treating underlying risk factors for CVD such as hypertension, dyslipidemia, obesity and / or diabetes.

A method of assessing risk for an individual to experience a specific outcome within a disease entity within a specified time frame is provided. Peer-reviewed scientific publications are analyzed to identify pertinent risk factors (212) for developing disease processes and their possible complications. Information that characterizes an individual (218) in relation to the identified risk factors is then received, preferably responsive to question (224) regarding any demographic values of an individual under test and questions regarding medical chracterisitics of the individual under test. An estimate of risk of the individual acquiring the outcome within a specified time frame is performed based on the identified plurality of risk factors (212). Assessment of medical risk and condition may include analyzing peer-reviewed scientific publications to identify populations affected by a medical outcome and for each population respective risk factors that affect risk of acquiring the medical outcome within a specified time-frame, associating an individual with one of the identified population, identifying information that characterizes the individual (218) in relation to the respective risk factors other associated population, and estimating risk of the individual having the medical outcome within the specified the time frame responsive to the identified information. Promotion of business on a site of a computer network is provided by supplying an on-line questionnaire (224) regarding characteristics of individual (218) under test, receiving information regarding characteristics of the individual under test, and responsive to the received information, providing an assessment of the individual under test having a medical outcome within a specified time frame.

Certain embodiments of the present invention provide a system for vulnerability detection and scoring with threat assessment including an analysis engine adapted to perform at least one of automated and semi-automated analysis of a computing system of at least one of known threats, vulnerabilities, and risk factors. The analysis engine is further adapted to determine a security score for the computing system based on the analysis and a schedule indicating a severity level for each threat, vulnerability, and risk factor.

The present invention relates to methods of assessing disease susceptibility associated with dietary and lifestyle risk factors. The invention provides for analysis of alleles at loci of genes associated with lifestyle risk factors, and the disease susceptibility profile of an individual is determined by reference to datasets which further match the risk factor with lifestyle recommendations in order to produce a personalized lifestyle advice plan.

A computer-implemented process of developing a person-level cost model for forecasting future costs attributable to claims from members of a book of business, where person-level data are available for a substantial portion of the members of the book of business for an actual underwriting period, and the forecast of interest is for a policy period is disclosed. The process uses development universe data comprising person-level enrollment data, historical base period health care claims data and historical next period claim amount data for a statistically meaningful number of individuals. The process also provides at least one claim-based risk factor for each historical base period claim based on the claim code associated with the health care claim and provides at least one enrollment-based risk factor based on the enrollment data. The process also develops a cost forecasting model by capturing the predictive ability of the main effects and interactions of claim based risk factors and enrollment-based risk factors, with the development universe data through the application of an interaction capturing technique to the development universe data.

A system for evaluating risk in an electronic banking transaction by estimating an aggregated risk value from a set of risk factors that are either dependent or independent of each other, comprising: user input means for enabling an end user to provide authentication information related to a desired electronic banking transaction; financial institution authentication means for authenticating that an end user is authorized to conduct the desired electronic transaction; risk computation means for imposing authentication requirements upon the end user in adaptation to a risk value of the desired banking electronic banking transaction; transaction session means for tracking an amount of time that the desired electronic banking transaction is taking; and financial institution transaction means for storing data related to the desired electronic banking transaction.

A computer-implemented method for generating a risk assessment regarding a software implementation project includes accessing a previously specified importance value and maximum score for each of a multiple of risk factors. The importance value for each risk factor reflects experience of an implementing entity regarding the extent to which the factor may negatively impact a software implementation project if the factor is not adequately addressed, the importance value and maximum score for each factor being multiplied to define a potential weighted score for the factor. An actual score for a particular software implementation project is received for each factor based on an analysis specific to the particular project. An actual weighted score for the particular project is generated for each factor by multiplying the importance value and actual score for the factor, and a relationship between the potential weighted score and actual weighted score for each factor. A risk level for the particular project is assigned to each factor according to the relationship between the potential weighted score and the actual weighted score for the factor. The risk level for each factor represents an assessment regarding the extent to which the factor may negatively impact the particular project if the factor is not adequately addressed. A risk assessment is generated for the particular project including one or more of the assigned risk levels for the particular project for one or more corresponding factors.

A computer implemented method, apparatus, and computer program product for generating general risk scores for general risk cohorts. Digital sensor data associated with a general risk cohort is received from a set of multimodal sensors. The digital sensor data comprises metadata describing attributes associated with at least one member of the general risk cohort. Each member of the general risk cohort comprises data describing objects belonging to a category. A general risk score for the general risk cohort is generated based on selected risk factors and the attributes associated with the at least one member of the general risk cohort. In response to a determination that the general risk score exceeds a risk threshold, a response action is initiated.

An implantable medical device and method are provided for assessing autonomic tone and risk factors associated with arrhythmias and, based on this assessment, an early recurrence of ventricular tachycardia or ventricular fibrillation is predicted. Specifically, changes in R—R interval, heart rate variability, patient activity, and myocardial ischemia are measured prior to and after a detected an arrhythmia episode. A recurrence score is calculated as a weighted sum of measured parameters and compared to a prediction criterion. The prediction criterion may be a preset threshold score or an individualized episode template based on previously calculated recurrence scores associated with recurring episodes. Stored parameters and episode-related data may be downloaded for offline analyses for optimizing prediction criteria and monitoring patient status.

A method for assessing susceptibility of a subject to a genetically related disease or condition relative to a general population. The method includes the steps of: determining the presence or absence of a plurality of risk factors associated with the subject and having a correlation with the disease or condition; assigning a risk score, to each of the selected risk factors determined to be present, based upon a strength of correlation assigned to the factor with respect to the disease or condition; and combining the risk scores to calculate an overall susceptibility score, wherein the overall susceptibility score represents susceptibility of the subject to the disease or condition in relation to a base score representing the risk that a member of the general population will have the disease or condition without consideration of risk factors. The risk factors require the inclusion of at least two of age, gender, race, and family history and require the inclusion of a plurality of polymorphisms selected for known correlation with the disease or condition.

A patient is diagnosed and a regimen of treatment is prescribed in a system which tests the patients, receives test results from a patient, including DNA test results. A database of human genome data correlating human health disorder with DNA genetic tests is accessed. A database of environmental factors which correlate known human health disorders with environmental conditions is accessed. Risk factors including genetic risk and environmental risk are developed, and from these, a composite risk factor is developed. This is used to access a database of prescribed drug therapy.

The invention provides a method and a system for predicting cardiovascular and cerebrovascular disease risks. The method comprises the following steps: step 1, defining problems of cardiovascular and cerebrovascular disease prognosis risk prediction, step 2, collecting health medical data of cardiovascular and cerebrovascular disease patients; step 3, preprocessing data, including data integration, data cleaning, and processing missing data; step 4, constructing features and selecting features, identifying potential risk factors; step 5, the identified risk factors and rehabilitation outcomes forming an input-output sample set, inputting the input-output sample set to a random forest algorithm for model training, and evaluating prediction performance of a model. The method and the system can obtain health medical data of cardiovascular and cerebrovascular disease patients, the data being required by a clinician input model, and a predicted rehabilitation outcome of a patient in a certain time period in future is obtained through the model. The method and the system can preferably predict prognosis risks, so as to realize personalized accurate rehabilitation treatment.

The present invention relates to methods and kits for reducing the occurrence of preterm delivery and other pregnancy-related conditions in pregnant female subjects exhibiting one or more risk factors for preterm delivery and other pregnancy-related conditions. For example, the present invention relates to methods for reducing the occurrence of preterm delivery in a pregnant female subject having no history of preterm delivery and exhibiting one or more risk factors for preterm delivery (e.g., smoking during pregnancy). The methods and kits provide for the administration of a steroid hormone to the pregnant female subject.

An electronic trading system facilitates electronic trades of fungible trading elements. Fungible trading elements are electronically displayed and the system facilitates the trading operations. A risk factor for a particular transaction may be determined and based on this risk factor, the electronic trading system may elect straight through processing (STP) operations to conclude a trade. Otherwise the risk factor may indicate avoiding the STP and allowing other settlement means. The electronic trading system also include the dematerialization of the trading elements, therefore verifying ownership prior to exchange and as such as more robust and secure trading platform.

The invention relates to systems and methods for assessing blood flow in single or multiple vessels and segments, for assessing vascular health, for conducting clinical trials, for screening therapeutic interventions for effect, for assessing risk factors, for evaluating intracranial pressure and for analyzing the results in a defined manner. The invention enables direct monitoring of therapies, substances and devices on blood vessels, especially those of the cerebral vasculature. Relevant blood flow parameters include mean flow velocity, systolic acceleration, and pulsatility index. Measurement and analysis of these parameters, and others, provides details regarding the vascular health of individual and multiple vessels and a global analysis of an individual's overall vascular health. The invention is applicable as both a system and method for monitoring and improving the design, performance, marketing and use of vascular stents. In particular, the invention enables DVA-assisted stenting procedures, including both pre-operative and post-operative management.

The present invention relates generally to systems and methods for assessing blood flow in blood vessels, for assessing vascular health, for conducting clinical trials, for screening therapeutic interventions for adverse effects, and for assessing the effects of risk factors, therapies and substances, including therapeutic substances, on blood vessels, especially cerebral blood vessels, all achieved by measuring various parameters of blood flow in one or more vessels and analyzing the results in a defined matter. The relevant parameters of blood flow include mean flow velocity, systolic acceleration, and pulsatility index. By measuring and analyzing these parameters, one can ascertain the vascular health of a particular vessel, multiple vessels and an individual. Such measurements can also determine whether a substance has an effect, either deleterious or advantageous, on vascular health. In one of many embodiments, the present invention further provides an expert system for achieving the above.

Methods are provided for reducing serum proinsulin levels, lessening post-prandial pancreatic stress, and reducing risk factors for atherosclerosis in subjects with diabetes mellitus, type 2. The method includes administration of insulin in a manner that mimics the meal-related first phase insulin response, using a dose sufficient to reduce serum levels of proinsulin. In some embodiments of the method insulin administration is commenced early in the course of the disease. Mimicking first phase kinetics, peak serum insulin levels can be reached within about 18 minutes of administration. In increasingly preferred embodiments peak serum insulin levels can be reached within about 15, 12, or 10 minutes of administration. Serum insulin levels return to baseline within about two hours of administration.

The invention provides a rule engine-based method and a rule engine-based system for monitoring exceptional service of bank. The method mainly comprises the followings steps: defining and describing operational risk factors of bank service flows, products and service units; determining a lost data and risk data collecting frame to analyze important lost data to determine a cause-and-effect relationship between loss events and risk factors; determining a key risk indicator (KPI); measuring a possible loss amount and a risk probability; measuring the effectiveness of the current management and control method, and making a more effective management and control scheme; deciding and implementing an efficiency and phase equilibrium-based management and control system; and effectively monitoring risk early warning indexes, risk reports aiming at senior management and the risk management and control method. Operational risks of commercial banks are comprehensively monitored, and risks are ensured to be controlled. The system is divided according to logical levels and comprises a service data layer, a data acquisition layer, a data storage layer, a risk processing layer, a risk management layer and an information presentation layer.

Embodiments of the invention generally relate to predicting the likelihood of an error in a previously filed tax return. In particular, a set of screening questions is presented to a user that correlate to set of risk factors for an erroneous return. Based on the responses to the screening questions, a likelihood of error and an expected magnitude of error are calculated. Based on the likelihood of error and the expected magnitude of error, an error score and a recommendation of whether to re-prepare and refile an amended tax return is presented.